Camlin Fine Sciences Ltd
Camlin Fine Sciences Ltd (CAMLINFINE) last traded at ₹106, a market capitalisation of ₹2,044 crore. Over the past 52 weeks the stock has ranged between ₹96.2 and ₹235. Camlin Fine Sciences Ltd last reported results for the quarter ended Jun 2026, with sales of ₹520 crore and net profit of ₹-34 crore. Figures are as of 25 Aug 2026 and are not real time.
Camlin Fine Sciences Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Camlin Fine Sciences Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹520 cr, up 27.5% from ₹408 cr a year earlier. Net profit was ₹-34 cr, down 209.1% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 417 | 431 | 432 | 408 | 460 | 441 | 425 | 520 |
| Expenses | 366 | 375 | 370 | 387 | 427 | 420 | 404 | 511 |
| Operating profit | 52 | 56 | 62 | 20 | 33 | 21 | 21 | 9 |
| OPM % | 12% | 13% | 14% | 5.0% | 7% | 4.7% | 5.0% | 1.8% |
| Other income | -151 | -8 | -22 | -0 | -4 | -24 | 103 | -10 |
| Interest | 26 | 34 | 15 | 15 | 19 | 17 | 23 | 14 |
| Depreciation | 17 | 14 | 17 | 16 | 19 | 16 | 21 | 19 |
| Profit before tax | -142 | -0 | 8 | -11 | -9 | -37 | 80 | -34 |
| Tax % | -18% | 2,164% | 98% | -0% | 65% | -0% | -8% | -1% |
| Net profit | -116 | -7 | 0 | -11 | -15 | -37 | 86 | -34 |
| EPS (₹) | -5.33 | -0.22 | -0.04 | -0.53 | -0.76 | -1.89 | 4.59 | -1.65 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Camlin Fine Sciences Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 1,187 | 1,412 | 1,682 | 1,454 | 1,629 | 1,723 | 1,845 |
| Operating profit | 187 | 158 | 211 | 170 | 227 | 118 | 84 |
| OPM % | 16% | 11% | 13% | 12% | 14% | 7% | 4.6% |
| Net profit | 65 | 60 | 40 | -105 | -158 | 24 | 1 |
| EPS (₹) | 3.56 | 3.45 | 2.96 | -4.94 | -7.40 | 1.44 | 0.29 |
TTM is the trailing twelve months to the most recent quarter.
Camlin Fine Sciences Ltd growth and returns
- 10 Years
- 13%
- 5 Years
- 8%
- 3 Years
- 1%
- TTM
- 9%
- 10 Years
- -1%
- 5 Years
- -6%
- 3 Years
- -14%
- TTM
- -139%
- 10 Years
- 2%
- 5 Years
- -8%
- 3 Years
- -11%
- 1 Year
- -52%
- 10 Years
- -1%
- 5 Years
- -2%
- 3 Years
- -7%
- Last Year
- 4%
Camlin Fine Sciences Ltd shareholding pattern
Promoters held 48.03% at Jun 2026, down from 49.09% at Jun 2025. FIIs 0.91% and DIIs 5.42%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 48.03% | 48.03% | 49.09% | 49.09% | 49.08% | 48.03% | 48.03% | 48.03% |
| FIIs | 0.81% | 0.76% | 1.47% | 2.88% | 2.11% | 2.12% | 0.94% | 0.91% |
| DIIs | 4.23% | 3.38% | 3.83% | 4.14% | 5.48% | 7.77% | 7.70% | 5.42% |
| Public | 46.93% | 47.83% | 45.61% | 43.88% | 43.33% | 42.07% | 43.31% | 45.63% |
| No. of shareholders | 67,750 | 61,893 | 58,111 | 59,538 | 57,661 | 52,357 | 52,232 | 55,178 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Camlin Fine Sciences Ltd corporate filings
- Transcript of the Earnings Call Q1FY27Company Updatehigh impact
Cruxal's analysis: Camlin Fine Sciences reported Q1 FY27 revenue of INR519.9 crore, reflecting a 28% YoY…
Read the full analysis - Newspaper Publication - Unaudited Financial Results for the quarter ended June 30, 2026.Company Updatehigh impact
Cruxal's analysis: Camlin Fine Sciences Limited reported its financial results for the quarter ended June…
Read the full analysis - Investor Call Recording Q1 FY27Company Updatelow impact
Cruxal's analysis: Camlin Fine Sciences Ltd has filed the audio recording of its Q1 FY27 investor conference…
Read the full analysis - Investor Presentation Q1 FY27Company Updatehigh impact
Cruxal's analysis: Camlin Fine Sciences Limited reported Q1 FY27 revenue of 519.8 crore, a 27.5% YoY…
Read the full analysis - Un-audited Financial Results for the quarter ended June 30, 2026Resulthigh impact
Cruxal's analysis: Camlin Fine Sciences Limited reported a consolidated net loss of 33.62 crore for the…
Read the full analysis - Proceedings of the 33rd AGMAGM/EGMlow impact
Cruxal's analysis: Camlin Fine Sciences Limited has successfully concluded its 33rd Annual General Meeting…
Read the full analysis - Schedule of Investor Meet - Q1FY27 Earnings CallCompany Updatelow impact
Cruxal's analysis: Camlin Fine Sciences Limited announced it will host a conference call with various…
Read the full analysis - Camlin Fine Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve the Un-audited Standalone ....Board Meetinglow impact
Cruxal's analysis: Camlin Fine Sciences Limited announced a board meeting scheduled for August 11, 2026, to…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Camlin Fine Sciences Ltd
Cruxal reads every Camlin Fine Sciences Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.